Inhibition of MAP4K4 mitigates cardiac insufficiency by promoting S-nitrosylation of Drp1 by inhibiting GPX4 expression, leading to mitochondrial dysfunction and cardiac microvascular disease, thereby exacerbating cardiac insufficiency. The gene discussed is MAP4K4; the disease is heart failure.